Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.

Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A.

Am J Cardiol. 2011 Feb 15;107(4):552-7. doi: 10.1016/j.amjcard.2010.10.012. Epub 2010 Dec 22.

2.

A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.

Ahmed MI, White M, Ekundayo OJ, Love TE, Aban I, Liu B, Aronow WS, Ahmed A.

Eur Heart J. 2009 Aug;30(16):2029-37. doi: 10.1093/eurheartj/ehp222. Epub 2009 Jun 16.

3.

Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.

Qualls LG, Greiner MA, Eapen ZJ, Fonarow GC, Mills RM, Klaskala W, Hernandez AF, Curtis LH.

Clin Cardiol. 2013 Dec;36(12):757-65. doi: 10.1002/clc.22206. Epub 2013 Oct 1.

4.

Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.

Hess PL, Greiner MA, Fonarow GC, Klaskala W, Mills RM, Setoguchi S, Al-Khatib SM, Hernandez AF, Curtis LH.

Clin Cardiol. 2012 Nov;35(11):649-57. doi: 10.1002/clc.22064. Epub 2012 Oct 15.

5.

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

JAMA. 2003 Nov 26;290(20):2685-92.

PMID:
14645310
6.

Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.

Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A.

Int J Cardiol. 2012 Jan 26;154(2):128-33. doi: 10.1016/j.ijcard.2010.09.006. Epub 2010 Oct 14.

7.

Aniticoagulation in patients following prosthetic heart valve replacement.

Akhtar RP, Abid AR, Zafar H, Khan JS.

Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):10-7.

PMID:
19262444
8.

Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.

Gheorghiade M, Flaherty JD, Fonarow GC, Desai RV, Lee R, McGiffin D, Love TE, Aban I, Eichhorn EJ, Bonow RO, Ahmed A.

Int J Cardiol. 2011 Aug 18;151(1):69-75. doi: 10.1016/j.ijcard.2010.04.092. Epub 2010 Jun 16.

9.

Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).

Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A.

Am J Cardiol. 2010 Jul 15;106(2):221-7. doi: 10.1016/j.amjcard.2010.02.032.

10.
11.

Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy.

Van Nooten GJ, Caes F, François K, Van Bellleghem Y, Bové T, Vandenplas G, Taeymans Y.

J Heart Valve Dis. 2012 Jan;21(1):88-98.

PMID:
22474748
12.

Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation.

Sadanaga T, Kohsaka S, Mitamura H, Ogawa S.

Heart Vessels. 2011 Sep;26(5):530-5. doi: 10.1007/s00380-010-0084-2. Epub 2010 Dec 25.

PMID:
21188387
13.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Grifoni, Elena [corrected to Grifoni, Elisa].

14.

Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, Martin DO, Hussein A, Khoury M, Abi-Saleh B, Alam S, Sengupta J, Borek PP, Baranowski B, Niebauer M, Callahan T, Varma N, Chung M, Tchou PJ, Kanj M, Dresing T, Lindsay BD, Wazni O.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):460-6. doi: 10.1161/CIRCEP.113.000320. Epub 2013 Apr 3. Erratum in: Circ Arrhythm Electrophysiol. 2013 Oct;6(5):e79.

15.

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2662-8. doi: 10.2215/CJN.04550511. Epub 2011 Sep 29.

16.

Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.

Ripley TL, Harrison D, Germany RE, Adamson PB.

Clin Ther. 2010 Mar;32(3):506-14. doi: 10.1016/j.clinthera.2010.03.001.

PMID:
20399987
18.

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.

Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A.

Eur Heart J. 2013 May;34(20):1489-97. doi: 10.1093/eurheartj/eht120. Epub 2013 Apr 16.

19.

Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).

Ashburner JM, Go AS, Reynolds K, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE.

Am J Cardiol. 2015 Jan 1;115(1):40-6. doi: 10.1016/j.amjcard.2014.10.006. Epub 2014 Oct 12.

PMID:
25456871
20.

Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.

Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.

Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):567-74. doi: 10.1161/CIRCOUTCOMES.113.000192. Epub 2013 Aug 6. Erratum in: Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):e59.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk